[Use of automated bactec MGIT 960 system in the diagnosis of resistance to reserve drugs agents in Samara].
The paper gives the results of a demonstration project to introduce a test for drug sensitivity to second-line antituberculous agents for patients with multidrug-resistant (MDR) tuberculosis at a routine large Russian laboratory. Two hundred and thirty MDR isolates were examined; of them 8.7% had extreme drug resistance. The cost of this test was estimated to be US $ 33.4. The introduction of this test is possible and essential for the precise and timely choice of antituberculous therapy for patients with MDR tuberculosis.
Balabanova
Ia M
IaM
Fedorin
I M
IM
Malomanova
N A
NA
Drobnievskiĭ
F
F
Nikolaevskiĭ
V V
VV
Sun
H
H
Mashkova
Iu A
IuA
Simak
T G
TG
Kontsevaia
I S
IS
Ignat'eva
O A
OA
Mironova
S A
SA
D000995:Antitubercular Agents / Q000494:pharmacology*; D002947:Cities; D024901:Drug Resistance, Multiple, Bacterial; D004867:Equipment Design; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests / Q000191:economics / Q000295:instrumentation*; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D015203:Reproducibility of Results; D012426:Russia; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis* / Q000188:drug therapy
D000995:Antitubercular Agents